Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$947K Buy
2,616
+99
+4% +$33.9K 0.03% 127
2026
Q1
$886K Buy
2,517
+73
+3% +$26K 0.03% 119
2025
Q4
$800K Sell
2,444
-194
-7% -$61.5K 0.02% 122
2025
Q3
$745K Buy
2,638
+414
+19% +$120K 0.02% 126
2025
Q2
$621K Buy
2,224
+1,435
+182% +$407K 0.02% 128
2025
Q1
$246K Buy
+789
New +$233K 0.01% 183
2024
Q4
Sell
-1,490
Closed -$480K 201
2024
Q3
$480K Buy
1,490
+46
+3% +$15K 0.02% 128
2024
Q2
$451K Buy
1,444
+11
+0.8% +$3.23K 0.02% 133
2024
Q1
$408K Buy
1,433
+34
+2% +$9.95K 0.02% 133
2023
Q4
$376K Hold
1,399
0.02% 125
2023
Q3
$376K Buy
1,399
+236
+20% +$58.9K 0.02% 125
2023
Q2
$258K Sell
1,163
-136
-10% -$31.6K 0.02% 149
2023
Q1
$314K Buy
1,299
+69
+6% +$16.9K 0.02% 130
2022
Q4
$323K Sell
1,230
-108
-8% -$29K 0.02% 119
2022
Q3
$302K Buy
1,338
+59
+5% +$14.3K 0.02% 113
2022
Q2
$311K Buy
1,279
+145
+13% +$35.5K 0.02% 113
2022
Q1
$274K Buy
1,134
+3
+0.3% +$689 0.02% 116
2021
Q4
$254K Sell
1,131
-25
-2% -$5.28K 0.02% 121
2021
Q3
$246K Sell
1,156
-30
-3% -$6.91K 0.02% 125
2021
Q2
$289K Buy
1,186
+29
+3% +$7.13K 0.03% 110
2021
Q1
$288K Hold
1,157
0.04% 106
2020
Q4
$259K Buy
+1,157
New +$267K 0.05% 93

Other funds holding AMGN

Foster Group's AMGN Position: Q2 2026 in Review

Foster Group increased its Amgen (AMGN) stake by 3.9% in Q2 2026, buying an estimated $33.9K and bringing the position to 2,616 shares worth $947K. The position accounts for 0.03% of the portfolio, ranked #127.

Foster Group first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Foster Group held 2,616 shares of Amgen worth $947K as of Q2 2026.
  • Foster Group bought 99 Amgen shares in Q2 2026, an estimated $33.9K.
  • Amgen made up 0.03% of Foster Group's portfolio in Q2 2026, its #127 holding.
  • Foster Group first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.